tolvaptan has been researched along with Hepatitis C in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellos, I; Kontzoglou, K; Perrea, DN | 1 |
1 review(s) available for tolvaptan and Hepatitis C
| Article | Year |
|---|---|
Predictors of tolvaptan short-term response in patients with refractory ascites: A meta-analysis.
Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Blood Urea Nitrogen; Body Weight; C-Reactive Protein; Forecasting; Hepatitis C; Humans; Time Factors; Tolvaptan | 2020 |